These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 26341250

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes.
    Eroglu FK, Yazar V, Guler U, Yıldırım M, Yildirim T, Gungor T, Celikkaya E, Karakaya D, Turay N, Ciftci Dede E, Korkusuz P, Salih B, Bulbul M, Gursel I.
    Am J Physiol Renal Physiol; 2021 Nov 01; 321(5):F659-F673. PubMed ID: 34569252
    [Abstract] [Full Text] [Related]

  • 33. Circannual variation in the onset and relapse of steroid-sensitive nephrotic syndrome.
    Toyabe S, Nakamizo M, Uchiyama M, Akazawa K.
    Pediatr Nephrol; 2005 Apr 01; 20(4):470-3. PubMed ID: 15719252
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prediction of relapse by plasma lipoprotein(a) concentration in children with steroid-sensitive nephrotic syndrome.
    Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H.
    Nephron; 2002 Dec 01; 92(4):807-11. PubMed ID: 12399624
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
    Kamei K, Ogura M, Sato M, Sako M, Iijima K, Ito S.
    Pediatr Nephrol; 2016 Jan 01; 31(1):89-95. PubMed ID: 26341251
    [Abstract] [Full Text] [Related]

  • 39. Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.
    Kemper MJ, Meyer-Jark T, Lilova M, Müller-Wiefel DE.
    Clin Nephrol; 2003 Oct 01; 60(4):242-7. PubMed ID: 14579938
    [Abstract] [Full Text] [Related]

  • 40. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
    Tain YL, Liu CA, Yang KD.
    Pediatr Nephrol; 2002 Nov 01; 17(11):926-32. PubMed ID: 12432436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.